Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2021
Reporting Period: The filing announces preliminary results for the fourth quarter and fiscal year ended December 31, 2020. Note: The text contains a typographical error stating "December 31, 2021" in the body, but the exhibit title and context confirm the fiscal year ended December 31, 2020.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the provided text.
Material Changes
The filing serves as a notification of the announcement of preliminary financial results. No specific material changes, variances, or comparative data versus prior periods are detailed in the text of this Form 8-K.
Guidance, Outlook, and Risks
Management Commentary: The Company announced preliminary results via a press release dated January 13, 2021.
Legal Status of Information: The information in the attached press release is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section, except as expressly set forth by specific reference.
Guidance/Risks: The text does not contain specific guidance, outlook, risk factors, or details on unusual items.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual financial figures, as they are not present in the 8-K text.
- Verify the fiscal year end date (December 31, 2020) against the press release to confirm the typo in the 8-K body text.
- Confirm the status of the Interim Chief Financial Officer, Henry Hagopian, who signed the report.
- Check for any subsequent filings that may provide audited or detailed financial statements following this preliminary announcement.